![](/img/cover-not-exists.png)
Long-Term Follow-Up of Patients With Hypereosinophilic Syndrome Treated With Alemtuzumab, an Anti-CD52 Antibody
Strati, Paolo, Cortes, Jorge, Faderl, Stefan, Kantarjian, Hagop, Verstovsek, SrdanVolume:
13
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2012.09.018
Date:
June, 2013
File:
PDF, 251 KB
english, 2013